CLCN1 and myotonic dystrophy type 1: We also reported that ~1.5-folds upregulation of MBNL1 protein by phenylbutazone, a non-selective NSAID, reversed missplicing of Clcn1, Nfix, and Rpn2, and improved muscle weakness in a DM1 mouse model21.